feed,title,long_url,short_url
Benzinga,Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer,https://benzinga.com/general/biotech/23/01/30477855/genentechs-tecentriq-plus-avastin-combo-cuts-risk-of-cancer-returning-in-early-stage-liver-cancer,https://da.gd/VBPo9q
